Medicare Enrolled
Carly Piel, PA-C
Physician Assistant · Bryn Mawr, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Piel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Piel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Piel
Carly Piel is a physician assistant in Bryn Mawr, PA, with 6 years of NPI registration. Based on federal Medicare data, Piel performed 4,705 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Piel received a total of $14,872 from 50 pharmaceutical and/or device companies across 441 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Piel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 6 years of NPI registration
▲ Top 1% volume in PA
$14,872 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,705
Medicare services
Top 1% in PA for physician assistant
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 3,000 | $2 | $6 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
489 | $3 | $8 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
284 | $60 | $213 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
266 | $84 | $301 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
189 | $9 | $69 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 73 | $124 | $800 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
63 | $60 | $212 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
57 | $35 | $77 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
54 | $2 | $10 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
50 | $81 | $250 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
49 | $56 | $117 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
31 | $54 | $300 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
25 | $24 | $100 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
22 | $8 | $12 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
22 | $43 | $149 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
17 | $93 | $215 |
| Fitting and insertion of vaginal support device A procedure to measure, fit, and insert a device designed to support vaginal structures. |
14 | $55 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$14,872
Total received (2021-2024)
Avg $3,718/year across 4 years
Top 1% in PA for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
441
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,005
2023
$4,211
2022
$2,631
2021
$2,024
Payments by company (2024)
Janssen Biotech, Inc.
$1,845
Astellas Pharma US Inc
$891
Bayer Healthcare Pharmaceuticals Inc.
$476
Axonics, Inc.
$418
Janssen Scientific Affairs, LLC
$408
Teleflex LLC
$307
DENTSPLY IH AB
$218
ABBVIE INC.
$197
Sumitomo Pharma America, Inc.
$184
Merck Sharp & Dohme LLC
$181
Ferring Pharmaceuticals Inc.
$146
AstraZeneca Pharmaceuticals LP
$80
180 Medical, Inc.
$80
UROGEN PHARMA, INC.
$77
Novartis Pharmaceuticals Corporation
$65
Telix Pharmaceuticals
$62
Tolmar, Inc.
$62
PFIZER INC.
$56
Medtronic, Inc.
$44
PROCEPT BioRobotics Corporation
$42
PROGENICS PHARMACEUTICALS, INC.
$42
Myriad Genetic Laboratories, Inc.
$38
Dendreon Pharmaceuticals LLC
$30
Antares Pharma, Inc.
$22
Endo USA, Inc.
$16
Mission Pharmacal Company
$16
Top 3 companies account for 53.5% of 2024 payments
All-time payments by company (2021-2024) ›
Janssen Biotech, Inc.
$3,207
Astellas Pharma US Inc
$2,314
Teleflex LLC
$1,280
Axonics, Inc.
$806
Bayer Healthcare Pharmaceuticals Inc.
$737
PFIZER INC.
$707
Janssen Scientific Affairs, LLC
$675
Merck Sharp & Dohme LLC
$444
180 Medical, Inc.
$417
Progenics Pharmaceuticals, Inc.
$381
DENTSPLY IH AB
$359
Dendreon Pharmaceuticals LLC
$331
Sumitomo Pharma America, Inc.
$329
Medtronic, Inc.
$311
ABBVIE INC.
$214
Myovant Sciences Inc.
$190
PROCEPT BioRobotics Corporation
$189
COLOPLAST CORP
$148
ConvaTec Inc.
$147
Ferring Pharmaceuticals Inc.
$146
Astellas Pharma Global Development
$123
UROVANT SCIENCES INC
$107
Telix Pharmaceuticals
$105
Antares Pharma, Inc.
$94
Boston Scientific Corporation
$92
Tolmar, Inc.
$86
AstraZeneca Pharmaceuticals LP
$80
UROGEN PHARMA, INC.
$77
DENTSPLY IH Inc.
$76
Novartis Pharmaceuticals Corporation
$65
Bayer HealthCare Pharmaceuticals Inc.
$64
Acerus Pharmaceuticals Corporation
$62
Myriad Genetic Laboratories, Inc.
$55
Amgen Inc.
$55
Mission Pharmacal Company
$46
Clarus Therapeutics Inc.
$44
PROGENICS PHARMACEUTICALS, INC.
$42
Janssen Pharmaceuticals, Inc
$32
Rochester Medical Corporation
$26
Curium US LLC
$26
TOLMAR Pharmaceuticals, Inc.
$23
Merck Sharp & Dohme Corporation
$23
AbbVie Inc.
$22
ABC Home Medical Supply, Inc.
$21
Coloplast Corp
$20
Smith+Nephew, Inc.
$16
Endo USA, Inc.
$16
UroGen Pharma, Inc.
$16
Supernus Pharmaceuticals, Inc.
$14
Sagent Pharmaceuticals, Inc.
$12
Top 3 companies account for 45.7% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Axonics · Axonics r-SNM System · BOTOX · Bulkamid · CURE CATHETER · ELIGARD · ERLEADA · GEMTESA · GENTLECATH · GRAFIX PL · Glydo · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LOFRIC · LUPRON DEPOT · LYNPARZA · LithoVue · LoFric · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Nubeqa · ORGOVYX · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · SELF CATH · SpeediCath · TALZENNA · URIBEL · URIBEL TABS · UROLIFT · Uribel · UroLift System · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Physician assistants in nearby ZIP areas
2,301
County median income
$88,576
Nearest hospital to ZIP centroid (approximate)
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Piel is a mixed practice specialist, with above-average Medicare volume (top 1% in PA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Piel experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Piel performed 3,000 bcg treatment for bladder cancer services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Piel receive payments from pharmaceutical companies?
Yes. Piel received a total of $14,872 from 50 companies across 441 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Piel's costs compare to other physician assistants in Bryn Mawr?
Piel's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Piel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Physician Assistants in Bryn Mawr
Browse physician assistants in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Physician Assistants in PA
Physician assistants ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Physician Assistants in PA
Which PA physician assistants receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology